EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Systemic staging in locoregional breast cancer recurrence: do contrast-enhanced CT and bone scintigraphy still add value?

Hayley Briody, Caroline Crotty, Gordon R Daly, Sharaf El Khatib, Christina Adesanya, Andrew Hynes, Sneha Singh, Gerard J Hill, Eithne Downey, Aoife McErlean, Aileen O'Shea, Neasa Ni Mhuircheartaigh und 5 weitere

British Journal of Radiology · 09.10.2026

DOI: 10.1093/bjr/tqag245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Radiology, online erschienen am 09.10.2026. Verfasst von Hayley Briody und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Beaumont Breast Centre, Beaumont Hospital, Dublin, Ireland. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Recent guidelines recommend computed tomography (CT) thorax, abdomen and pelvis (TAP) alone for systemic staging of primary breast cancer. However, evidence on imaging in breast cancer recurrence (BCR) is limited and CT TAP with bone scintigraphy is often performed. This study aims to determine the benefit of combination CT TAP and bone scintigraphy in BCR.

Methods

Patients presenting with BCR during the 15-year study period were identified from a prospectively maintained database. Definitive treatment of the primary breast cancer was required for inclusion. The institutional picture archiving and communication system was searched to identify patients who underwent CT TAP and bone scintigraphy for BCR. Sites of distant metastasis (DM) were recorded.

Results

227 patients with BCR were identified during the study period; 155(68.28%) patients underwent contrast-enhanced CT TAP with metastatic disease identified in 55(35.48%). Patients with grade 3 or triple negative breast cancer were more likely to have DM at time of BCR (P < .005). 95(41.85%) patients underwent bone scintigraphy and CT TAP. Bone scintigraphy did not identify bone metastasis in any patients without concurrent evidence of bone metastasis on CT.

Conclusion

CT TAP identified DM in over a third of patients with BCR who underwent restaging, a higher yield than seen in primary breast cancer staging. Bone scintigraphy did not identify osseous metastases in those without concurrent CT evidence of metastatic bone disease, suggesting limited additive value of bone scintigraphy when CT TAP is performed for BCR. Advances in knowledge This study provides evidence that CT TAP alone may be sufficient for systemic staging in BCR.

Schlagwörter

Stichwörter der Autor:innen

Breast cancer recurrencebone scintigraphysystemic staging

Autor:innen und Institutionen

  • Department of Radiology, Beaumont Breast Centre, Beaumont Hospital, Dublin, Ireland.
  • Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Department of Surgery, Beaumont Breast Centre, Beaumont Hospital, Dublin, Ireland.

Zitieren

APA

Briody, H., Crotty, C., Daly, G. R., El Khatib, S., Adesanya, C., Hynes, A., Singh, S., Hill, G. J., Downey, E., McErlean, A., O'Shea, A., Mhuircheartaigh, N. N., Hambly, N., Bambrick, M., Duke, D., D K Hill, A., & Healy, N. A. (2026). Systemic staging in locoregional breast cancer recurrence: do contrast-enhanced CT and bone scintigraphy still add value?. British Journal of Radiology. https://doi.org/10.1093/bjr/tqag245

Vancouver

Briody H, Crotty C, Daly GR, El Khatib S, Adesanya C, Hynes A, et al. Systemic staging in locoregional breast cancer recurrence: do contrast-enhanced CT and bone scintigraphy still add value?. British Journal of Radiology. 2026. doi:10.1093/bjr/tqag245

BibTeX
@article{Briody2026,
  author = {Briody, Hayley and Crotty, Caroline and Daly, Gordon R and El Khatib, Sharaf and Adesanya, Christina and Hynes, Andrew and Singh, Sneha and Hill, Gerard J and Downey, Eithne and McErlean, Aoife and O'Shea, Aileen and Mhuircheartaigh, Neasa Ni and Hambly, Niamh and Bambrick, Marie and Duke, Deirdre and D K Hill, Arnold and Healy, Nuala A},
  title = {Systemic staging in locoregional breast cancer recurrence: do contrast-enhanced CT and bone scintigraphy still add value?},
  journal = {British Journal of Radiology},
  year = {2026},
  doi = {10.1093/bjr/tqag245}
}
Kostenlos starten →